| [1] |
Hanahan D,Weinberg R A. Hallmarks of cancer: The next generation. [J].Cell, 2011, 144(5):646-674.
|
| [2] |
Siegel R L, Miller K D,Jemal A. Cancer statistics, 2017 [J].CA Cancer J Clin, 2017, 67(1):7-30.
|
| [3] |
Williams D. Medical nanotechnology: how small can we go? [J].Med Device Technol,2002, 13(3):7-9.
|
| [4] |
Moore A. Brave small world. Biotechnology and nanotechnology may give rise to a completely new industry [J].Embo Rep,2001, 2(2):86-88.
|
| [5] |
Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. [J].Clin Cancer Res,2008, 14(5):1310-1316.
|
| [6] |
Shi J, Kantoff P W, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. [J].Nat Rev Cancer,2017, 17(1):20-37.
|
| [7] |
Kobayashi H, Watanabe R,Choyke P L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? [J].Theranostics,2013, 4(1):81-89.
|
| [8] |
Smith AD. Big Moment for Nanotech: Oncology Therapeutics Poised for a Leap. Onclive.
|
| [9] |
US National Library of Medicine. ClinicalTrials.gov. 2016.
|
| [10] |
US National Library of Medicine. ClinicalTrials.gov. 2014.
|
| [11] |
US National Library of Medicine. ClinicalTrials.gov. 2015.
|
| [12] |
US National Library of Medicine. ClinicalTrials.gov. 2012.
|
| [13] |
Barenholz Y. Doxil(R)--the first FDA-approved nano-drug: lessons learned[J].J Control Release,2012, 160(2):117-134.
|
| [14] |
Petersen G H, Alzghari S K, Chee W, et al. Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin [J].J Control Release,2016, 232:255-264.
|
| [15] |
Gradishar W J, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer [J].J Clin Oncol,2005, 23(31):7794-7803.
|
| [16] |
Kato K, Chin K, Yoshikawa T, et al. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer [J].Invest New Drugs,2012, 30(4):1621-1627.
|
| [17] |
Maier H K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme [J].J Neurooncol, 2011, 103(2):317-324.
|
2017, Vol. 28 
